Technical Analysis for CPH - Cipher Pharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | -6.11% | |
| Earnings Movers | Other | -6.11% | |
| Gapped Up | Strength | -6.11% | |
| Oversold Stochastic | Weakness | -6.11% | |
| Hammer Candlestick | Bullish | -2.99% | |
| Stochastic Buy Signal | Bullish | -2.99% | |
| Lizard Bullish | Bullish Day Trade Setup | -2.99% | |
| Pocket Pivot | Bullish Swing Setup | -2.99% | |
| Doji - Bullish? | Reversal | -2.99% | |
| Gapped Up | Strength | -2.99% |
| Alert | Time |
|---|---|
| Gap Down Partially Closed | about 3 hours ago |
| Lower Bollinger Band Support | about 3 hours ago |
| Down 2 ATRs | about 3 hours ago |
| Down 1 ATR | about 3 hours ago |
| 3x Volume Pace | about 3 hours ago |
Get a Trading Sidekick!
- Earnings date: 2024-11-07
Cipher Pharmaceuticals Inc. Description
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pipe Pharma Pipeline Pharmaceutical RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Psoriasis Ulcer Dermatology Nail Rheumatoid Arthritis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Plaque Psoriasis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.69 |
| 52 Week Low | 4.82 |
| Average Volume | 73,942 |
| 200-Day Moving Average | 10.793 |
| 50-Day Moving Average | 16.222 |
| 20-Day Moving Average | 16.128 |
| 10-Day Moving Average | 15.438 |
| Average True Range | 0.687 |
| RSI (14) | 47.92 |
| ADX | 17.95 |
| +DI | 20.001 |
| -DI | 30.424 |
| Chandelier Exit (Long, 3 ATRs) | 16.298 |
| Chandelier Exit (Short, 3 ATRs) | 16.362 |
| Upper Bollinger Bands | 17.849 |
| Lower Bollinger Band | 14.407 |
| Percent B (%b) | 0.33 |
| BandWidth | 21.346 |
| MACD Line | -0.225 |
| MACD Signal Line | -0.084 |
| MACD Histogram | -0.1411 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.290 | ||||
| Resistance 3 (R3) | 16.213 | 15.887 | 16.165 | ||
| Resistance 2 (R2) | 15.887 | 15.696 | 15.925 | 16.123 | |
| Resistance 1 (R1) | 15.713 | 15.578 | 15.800 | 15.790 | 16.082 |
| Pivot Point | 15.387 | 15.387 | 15.430 | 15.425 | 15.387 |
| Support 1 (S1) | 15.213 | 15.196 | 15.300 | 15.290 | 14.998 |
| Support 2 (S2) | 14.887 | 15.078 | 14.925 | 14.957 | |
| Support 3 (S3) | 14.713 | 14.887 | 14.915 | ||
| Support 4 (S4) | 14.790 |
